Article
Gastroenterology & Hepatology
Giuseppe Biscaglia, Anna Latiano, Stefano Castellana, Rosanna Fontana, Annamaria Gentile, Tiziana Latiano, Giuseppe Corritore, Anna Panza, Marianna Nardella, Giuseppina Martino, Fabrizio Bossa, Francesco Perri, Tommaso Mazza, Angelo Andriulli, Orazio Palmieri
Summary: This study investigated germline alterations in patients with inflammatory bowel disease (IBD)-associated colorectal cancer (CRC). The results showed that a significant proportion of IBD patients with CRC had pathogenic variants in cancer-related genes. Those with pathogenic variants had earlier onset of high-grade dysplasia or CRC compared to patients with benign or unidentified variants. Screening for these genes could help identify IBD patients who require more intensive surveillance for early detection of dysplastic changes.
INFLAMMATORY BOWEL DISEASES
(2022)
Article
Gastroenterology & Hepatology
Tatsuki Noguchi, Soichiro Ishihara, Motoi Uchino, Hiroki Ikeuchi, Koji Okabayashi, Kitaro Futami, Shinji Tanaka, Hiroki Ohge, Hisashi Nagahara, Kazuhiro Watanabe, Michio Itabashi, Kinya Okamoto, Yoshiki Okita, Tsunekazu Mizushima, Yusuke Mizuuchi, Kazutaka Yamada, Yoshifumi Shimada, Yu Sato, Hideaki Kimura, Kenichi Takahashi, Koya Hida, Yusuke Kinugasa, Junji Okuda, Koji Daito, Fumikazu Koyama, Hideki Ueno, Takayuki Yamamoto, Tsunekazu Hanai, Atsuo Maemoto, Koji Oba, Yoichi Ajioka, Kenichi Sugihara
Summary: Patients with longstanding inflammatory bowel disease, such as ulcerative colitis and Crohn's disease, are at high risk of developing intestinal cancers. This study found significant differences between intestinal cancers associated with ulcerative colitis and Crohn's disease. Crohn's disease-associated cancers were diagnosed at more advanced stages, detected less frequently by surveillance, and had a poorer prognosis compared to those associated with ulcerative colitis.
JOURNAL OF GASTROENTEROLOGY
(2022)
Article
Gastroenterology & Hepatology
Frank Phillips, Bram Verstockt, Malgorzata Sladek, Nanne de Boer, Konstantinos Katsanos, Konstantinos Karmiris, Ahmad Albshesh, Carl Erikson, Daniel Bergemalm, Tamas Molnar, Pierre Ellul
Summary: There is a correlation between orofacial granulomatosis (OFG) and Crohn's disease (CD), which can occur before, concurrently with, or after CD diagnosis. Perianal and upper gastrointestinal diseases are common associations, with a significant symptom burden in many patients. Remission can be achieved with various immunosuppressive treatments, including several biologics approved for CD.
JOURNAL OF CROHNS & COLITIS
(2022)
Article
Gastroenterology & Hepatology
Julien Kirchgesner, Rishi J. Desai, Maria C. Schneeweiss, Laurent Beaugerie, Sebastian Schneeweiss, Seoyoung C. Kim
Summary: Combination therapy with vedolizumab and thiopurines is associated with a lower risk of treatment failure compared to vedolizumab monotherapy in patients with CD, but the effect is less pronounced in UC.
Article
Immunology
Yao Wang, Hao Zhuang, Xiao-han Jiang, Rui-han Zou, Hai-yang Wang, Zhi-ning Fan
Summary: Using WGCNA and random forest algorithm, this study identified nine gene signatures associated with the exacerbation of Ulcerative colitis (UC). A novel genotyping scheme was constructed to predict the severity of UC and screen UC patients suitable for CS-IV treatment. Furthermore, a small molecule drug (Exisulind) with potential therapeutic effects for UC was identified, providing new ideas and materials for personalized clinical treatment plans for UC patients.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Surgery
Can Lu, Josefine Schardey, Tao Zhang, Alexander Crispin, Ulrich Wirth, Konrad W. Karcz, Alexandr Bazhin, Joachim Andrassy, Jens Werner, Florian Kuehn
Summary: This study conducted a systematic review and meta-analysis to compare the survival outcomes of IBD-associated and non-IBD-associated CRC. The results showed that IBD-CRC patients had a significantly worse overall survival than those without IBD. This may be attributed to more aggressive histological characteristics and a lower rate of R0 resections at the primary tumor site.
Article
Psychology, Multidisciplinary
Felicitas Engel, Sabrina Berens, Annika Gauss, Rainer Schaefert, Wolfgang Eich, Jonas Tesarz
Summary: The study found that patients with CD/UC have higher levels of depression and anxiety compared to HC, and there are differences in personality functioning in the domain of self-perception and regulation. Minor differences were found in mentalization and attachment between CD/UC and HC.
FRONTIERS IN PSYCHOLOGY
(2021)
Article
Gastroenterology & Hepatology
Maia Kayal, David Kohler, Michael Plietz, Sergey Khaitov, Patricia Sylla, Alexander Greenstein, Marla C. Dubinsky
Summary: In this retrospective cohort analysis, early pouchitis was significantly associated with subsequent development of Crohn's disease-like pouch inflammation, indicating that early pouchitis may serve as an indicator of enhanced mucosal immune activation in the pouch.
INFLAMMATORY BOWEL DISEASES
(2022)
Article
Immunology
Jiang Deng, Ning Zhao, Li-ping Lv, Ping Ma, Yang-yang Zhang, Jin-bo Xu, Xi-peng Zhou, Zi-an Chen, Yan-yu Zhang
Summary: This study integrated data from multiple inflammatory bowel disease (IBD) cohorts to identify differentially expressed genes (DEGs) and establish a protein-protein interaction (PPI) network. Two differential diagnostic models were developed to distinguish between Crohn's disease (CD) and ulcerative colitis (UC). MMP-associated modules were found to be the main differential gene sets between CD and UC. The MMP-associated genes showed potential as biomarkers for the discrimination of IBD patients.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Immunology
Reza Yarani, Ali Shojaeian, Oana Palasca, Nadezhda T. Doncheva, Lars Juhl Jensen, Jan Gorodkin, Flemming Pociot
Summary: This review discusses the differential regulation of miRNAs in inflammatory bowel disease (IBD) and their potential diagnostic and therapeutic applications. Through literature curation and computational analysis, a consensus set of differentially expressed miRNAs in mucosal tissues was obtained. The role of these miRNAs and their potential targets in IBD are highlighted.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Oncology
Ruth Gabriela Herrera-Gomez, Miruna Grecea, Claire Gallois, Valerie Boige, Patricia Pautier, Barbara Pistilli, David Planchard, David Malka, Michel Ducreux, Olivier Mir
Summary: This study retrospectively evaluated the safety and efficacy of combining bevacizumab and chemotherapy in adult cancer patients with inflammatory bowel disease. The results showed that the combination treatment was safe in patients with quiescent or moderately active inflammatory bowel disease.
Article
Gastroenterology & Hepatology
Maxime K. Collard, Julien Tourneur-Marsille, Mathieu Uzzan, Miguel Albuquerque, Maryline Roy, Anne Dumay, Jean-Noel Freund, Jean-Pierre Hugot, Nathalie Guedj, Xavier Treton, Yves Panis, Eric Ogier-Denis
Summary: This study explored the mechanism underlying the increased risk of colorectal cancer associated with appendectomy in patients with ulcerative colitis. The results showed that appendectomy reduced colitis severity and increased cancer number, while appendicitis induction without appendectomy had the opposite effect. Blocking lymphocyte trafficking or injecting CD8+ or CD3+ T cells from the inflammatory neo-appendix suppressed the effects of appendectomy on tumor growth. In UC patients with a history of appendectomy, tumor-infiltrating T cell densities were decreased compared with those without appendectomy.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY
(2023)
Article
Biochemical Research Methods
Florent Clerc, Karli R. Reiding, Noortje de Haan, Carolien A. M. Koeleman, Agnes L. Hipgrave Ederveen, Natalia Manetti, Viktoria Dotz, Vito Annese, Manfred Wuhrer
Summary: This study investigates the associations of immunoglobulin A1 and A2 glycosylation with inflammatory bowel diseases (IBD). Differences in IgA O- and N-glycosylation between patient groups were found to be associated with the diseases, and a statistical model was constructed to predict the disease group of the patients. These findings contribute to the development of noninvasive biomarkers for IBD and improvement in patient care.
JOURNAL OF PROTEOME RESEARCH
(2023)
Article
Oncology
Josefine Schardey, Can Lu, Jens Neumann, Ulrich Wirth, Qiang Li, Tianxiao Jiang, Petra Zimmermann, Joachim Andrassy, Alexandr V. Bazhin, Jens Werner, Florian Kuehn
Summary: Chronic inflammation plays a significant role in the development of colorectal cancer, particularly in colitis-associated colorectal cancer. This study examined the differences in immune infiltration patterns between colitis-associated colorectal cancer and sporadic colorectal cancer and their impact on prognosis.
Review
Gastroenterology & Hepatology
Michael G. Fadel, Georgios Geropoulos, Oliver J. Warren, Sarah C. Mills, Paris P. Tekkis, Valerio Celentano, Christos Kontovounisios
Summary: This systematic review and meta-analysis identified age at UC diagnosis and pouch surgery, family history of IBD, and previous smoking as potential risk factors for the development of Crohn's disease of the pouch (CDP) following IPAA for ulcerative colitis (UC).
JOURNAL OF CROHNS & COLITIS
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Neeraj Lalwani, David D. B. Bates, Hina Arif-Tiwari, Ashish Khandelwal, Elena Korngold, Mark Lockhart
Summary: MRI has become the standard for baseline local tumor and nodal staging of rectal cancers, providing essential prognostic information and guiding treatment. A framework for imaging the rectum on MRI and interpreting pre-treatment MRI evaluations of rectal cancers is provided, which can be paired with standardized reporting templates for clear and accurate imaging assessment.
SEMINARS IN ROENTGENOLOGY
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
David D. B. Bates, Canan Firat, Jinru Shia, Maria Widmar
SEMINARS IN ROENTGENOLOGY
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
David D. B. Bates, James L. Fuqua, Junting Zheng, Marinela Capanu, Jennifer S. Golia Pernicka, Sidra Javed-Tayyab, Viktoriya Paroder, Iva Petkovska, Marc J. Gollub
Summary: Measurement of rectal tumor height on MRI is highly reproducible between readers, with measurements starting from EAS tending to slightly overestimate tumor height on average and from IAS tending to slightly underestimate tumor height on average.
ABDOMINAL RADIOLOGY
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
Vetri Sudar Jayaprakasam, Sidra Javed-Tayyab, Natalie Gangai, Junting Zheng, Marinela Capanu, David D. B. Bates, James L. Fuqua, Viktoriya Paroder, Jennifer Golia-Pernicka, Marc J. Gollub, Iva Petkovska
Summary: This study investigated the effect of using a microenema before rectal MRI to reduce gas-related artifacts on DWI sequences. Overall, there was a significant decrease in gas-related artifacts with microenema use, especially in post-TNT scans and scans conducted with a 3 T magnet. This method offers a promising solution to improve DWI quality.
ABDOMINAL RADIOLOGY
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
Vetri Sudar Jayaprakasam, Viktoriya Paroder, Peter Gibbs, Raazi Bajwa, Natalie Gangai, Ramon E. Sosa, Iva Petkovska, Jennifer S. Golia Pernicka, James Louis Fuqua, David D. B. Bates, Martin R. Weiser, Andrea Cercek, Marc J. Gollub
Summary: The study found that radiomics features of mesorectal fat can predict clinical outcomes in patients with rectal cancer, including pathological complete response, local and distant recurrence, as well as post-treatment T and N categories.
EUROPEAN RADIOLOGY
(2022)
Review
Oncology
David D. B. Bates, Maria El Homsi, Kevin J. Chang, Neeraj Lalwani, Natally Horvat, Shannon P. Sheedy
Summary: MRI plays a crucial role in the staging and treatment planning of rectal cancer, assessing tumor characteristics and treatment response. Close collaboration between radiologists and other medical experts is essential for providing optimal care.
CLINICAL COLORECTAL CANCER
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
David D. B. Bates, Hiram Shaish, Marc J. Gollub, Mukesh Harisinghani, Chandana Lall, Shannon P. Sheedy
Summary: The survey results revealed significant technical and reporting practice heterogeneity among respondents in MRI for rectal cancer, with most groups reading only a modest number of studies per week. The findings suggest there is room for improvement in radiologist education and standardization of clinical practice for MR imaging of rectal cancer.
ABDOMINAL RADIOLOGY
(2022)
Article
Oncology
Vetri Sudar Jayaprakasam, Peter Gibbs, Natalie Gangai, Raazi Bajwa, Ramon E. Sosa, Randy Yeh, Megan Greally, Geoffrey Y. Ku, Marc J. Gollub, Viktoriya Paroder
Summary: This study aimed to assess the usefulness of radiomics features of F-18-FDG PET/CT in predicting outcomes in patients with locally advanced esophageal cancers. The developed radiomics models were found to accurately predict clinical and prognostic outcomes, similar or better than those derived from conventional imaging.
Article
Oncology
Steven B. Maron, Walid Chatila, Henry Walch, Joanne F. Chou, Nicholas Ceglia, Ryan Ptashkin, Richard Kinh Gian Do, Viktoriya Paroder, Neeta Pandit-Taskar, Jason S. Lewis, Tiago Biachi De Castria, Shalom Sabwa, Fiona Socolow, Lara Feder, Jasmine Thomas, Isabell Schulze, Kwanghee Kim, Arijh Elzein, Viktoria Bojilova, Matthew Zatzman, Umesh Bhanot, Rebecca J. Nagy, Jeeyun Lee, Marc Simmons, Michal Segal, Geoffrey Yuyat Ku, David H. Ilson, Marinela Capanu, Jaclyn F. Hechtman, Taha Merghoub, Sohrab Shah, Nikolaus Schultz, David B. Solit, Yelena Y. Janjigian
Summary: The study highlights the clinical significance of identifying baseline intrapatient heterogeneity and serial ctDNA monitoring in HER2-positive esophagogastric cancer patients. These factors can be used to identify early evidence of treatment resistance, guiding proactive therapy escalation or deescalation.
CLINICAL CANCER RESEARCH
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Kevin J. J. Chang, David H. H. Kim, Tasneem K. K. Lalani, Viktoriya Paroder, Perry J. J. Pickhardt, Hiram Shaish, David D. B. Bates
Summary: Radiologic imaging, especially MRI, has been commonly used for rectal cancer staging and selecting neoadjuvant therapy. In contrast, colonoscopy and CT have been the standard for colon cancer diagnosis and metastasis staging. Recent trials have expanded the use of neoadjuvant therapy in colon cancer, leading to a renewed interest in the role of radiology in primary T staging. The performance of CT, CT colonography, MRI, and FDG PET-CT in colon cancer staging will be reviewed, with a focus on its impact on clinical decisions.
ABDOMINAL RADIOLOGY
(2023)
Review
Radiology, Nuclear Medicine & Medical Imaging
Viktoriya Paroder, Tyler J. Fraum, Stephanie Nougaret, Iva Petkovska, Gaiane M. Rauch, Harmeet Kaur
Summary: Total neoadjuvant therapy (TNT), including chemotherapy and radiation, has become the new standard of care for locally advanced rectal cancer. It improves local control and reduces the risk of recurrence. A significant percentage of patients achieve a complete clinical response and can avoid surgery through watch-and-wait protocols. Ongoing clinical trials are investigating long-term outcomes and better treatment regimens for this disease.
ABDOMINAL RADIOLOGY
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Snigdha Alur-Gupta, Hila Fruchtman, Viktoriya Paroder
Summary: Fertility preservation has become an important part of cancer care for reproductive-age women. Current treatments such as radiotherapy, chemotherapy, and surgery pose a high risk of fertility impairment. With improved survival rates, expanding reproductive options is a priority.
ABDOMINAL RADIOLOGY
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Marc J. Gollub, Stephanie Lobaugh, Jennifer S. Golia Pernicka, Cameron D. A. Simmers, David D. B. Bates, J. Louis Fuqua, Viktoriya Paroder, Iva Petkovska, Martin R. Weiser, Marinela Capanu
Summary: The study aimed to describe the cumulative incidence of peritoneal carcinomatosis (PC) and survival in patients with advanced rectal cancer staged with pelvic MRI. Results showed an association between MRI-based T stage and the cumulative incidence of PC, with cT4a stage having the highest CUIN descriptively.
EUROPEAN RADIOLOGY
(2022)